Bio-Synthesis offers synthetic polymer PEG (polyethylene glycol) modification and
bioconjugation services by site specific ligation of polyethylene glycol to peptide/portein,
oligonucleotide, antibodies, lectins, enzymes, toxins, druge or other small molecules
as delivery technoogy in variety of applications. The conjugation of PEG to a peptide
or protein has shown the possibility of improving the pharmacokinetic profile of
a linked drug. In the last few years this technology, firstly developed for proteins,
has been transferred to non-peptide drugs, opening a new area of investigation that
is now receiving increasing interest. This leads to new opportunities for many therapeutic
treatments as it is possible to use molecules that could not before be exploited
due to limitations such as inadequate water solubility, high nonspecific toxicity
and poor pharmacokinetic profiles.
Bio-Synthesis provide reliable and flexible chemical biology solutions that cover
almost all aspects you may encounter during the preparation phase in diagnostic
and drug discovery research. Our unique approach for a homogeneous PEGylated populations
where the specific PEGylation site can be selected and controlled, thus improving
efficacy compared to existing PEGylation techniques. All synthetic bioconjugation
project is metriculously monitored according to Bio-Synthesis's stringent quality
assurance and quality control standard that are fully backed up by an bioanalytical
PEG (polyethylene glyco), the most often used polymer. This chemical compound composed
of repeating ethylene glycol units. It also known as poly ethylene oxide (PEO) and
polyoxyethylene (POE) with molecular weights from 300g/mol to 10,000,000 g/mol.
with general structure HO-(CH2CH2O)n-H.
Conjugation of synthetic PEG with biopolymer sometimes called "bio-hybrid"
or "macromolecular chimera. Covalent modification
of a PEG polymer to a therapeutic moleucle called PEGylation. As peptide and protein
based therapeutics have become a continual focus for innovative drug discovery as
they offer key advantages over small molecules (e.g. lower toxicity profiles, and
increased specificity and affinity to target). There are, however, a few setbacks
in the development of effective peptide drugs including short half-life, rapid glomerular
filtration, and degradation by proteolytic enzymes. PEGylation is the reaction between
the functional group of activated polyethylene glycol and reactive residues on the
protein surface (such as lysine). It is a popular avenue used to overcome the disadvantages
associated with protein based drugs. PEGylation increases the therapeutic value
of peptides and proteins—PEG acts as a shield to protect the biopolymers from proteolysis,
increases the overall molecular weight which increases circulation half-life, decreases
immunogenicity by limiting uptake into dendritic cells (PEG itself is non-immunogenic),
and increases solubility of the protein. PEG polymers are available in various sizes
for the tuning of PEG-drug conjugate circulating half-lives and solubility.
Limitations: Traditional PEGylation involves the reaction of activated
PEG with a free amine (such as lysine on the peptide or protein surface) or at the
N-terminus. This non-site selective route leads to multiple attachments because
peptides and proteins can have several free amines. As a result, the conjugated
product can contain a mixture of molecules with PEG linked to various free amines.
The homogeneity of PEG conjugated products is compromised, making it difficult to
obtain reproducible monosubstituted PEG conjugates with the same effective biological
activities to fulfill regulatory criteria. An important consideration in PEGylation
is the relationship between the reaction site and bioactivity, i.e. receptor binding
may take place at the N-terminus or at other sites that are also reactive with activated
PEG. Non-site specific PEGylation may also lead to a product in which the conjugated
PEG masks or interferes with the receptor binding site, decreasing bioactivity up
to 100 fold in comparison to the unmodified protein. Thus, it is important to consider
controllable site-specific routes that offer high product yield and reproducibility
while preserving bioactivity.
In recent times, site-specific PEGylation is used to overcome the limitations of
non-selective strategies. A number of approaches for site-specific PEGylation have
been developed to allow for the incorporation of a single PEG moiety at a defined
position within the protein sequence. Site-specific PEGylation minimizes interference
of biological function and affords homogenous PEGylated products that are more easily
purified and reproduced. The general approach to site-specific PEGylation involves
the modification or addition of an amino acid that reacts exclusively with the PEG.
A common example is the addition of a cysteine to introduce a free reactive thiol.
Other chemical routes include the blocking of reactive residues, N or C-terminal
modification (e.g. introduction of a His tag, reductive alkylation, introduction
of a reactive hydrizide), click chemistry, and Staudinger ligation to name a few.
The chemistry is determined based on the protein or peptide sequence. Our chemists
at Bio-Synthesis are ready to work with you on your PEGylation project scope and
Contact our Technical Service Center at 800.220.0627 or contact us online
with your detail project specifications, a project manager will be assigned to help
you with design and develop an appropreate synthetic method for your specific needs.
Sample Submission Requirement:
Biomolecule supplied by customers should be sufficiently pure. Please provide 5
mgs of starting material with the necessary data for purity assessment. Commercial
available biopolymers can be supplied by customers or synthesize or ordered through
Price varies based on the project specifications. Our service includes materials
and labor for conjugation only! Price does not include the cost of biopolymer synthesis
or order through Bio-Synthesis from an commercial vendors and, if deemed necessary,
biopolymer modification to introduce additional functional groups, extra linkers,
spacers. Please contact us for a quote.
Discount: 15 % discount price applies to additional conjugates
ordered at the same time.
Chemistry: Coupling of preactivated small molecule and biomolecule
with chemical reactive groups such as amine, thiol, carboxylate, hydroxyl, aldehyde
and ketone, active hydrogen through use of varous cross linkers.
Type of PEG for Conjugation
Service Specification: After standard desalting, or purification,
a small percent of heterogeneous products containing single or multi-site conjugate
per molecule may exist.
Procedure: After labeling , final conjugates must first be isolated
from excess or unreacted reagent by gel filtration or dialysis. In many cases, simple
dialysis may suffice to remove unreacted reagent from the reaction solution. Additional
purification technique such as stirred cell filtration, tangential flow filtration
(TFF), gel filtration chromatography may also be used to either remove excess reagent
or isolate and characterized the cross-linked product. With exception of dialysis,
if the protein/antibody is significantly larger (>3-fold) than the modifying
or coupling reagent. For reagents (mostly protein and other biological molecules)
that are similar in size or larger than the antibody, one must resort to other purification
techniques such as affinity chromatography, ion-exchange chromatography, and hydrophobic
Cross-linked target molecule may then be further characterized by gel electrophoresis.
It may be subject to additional analyses with an addtional fee. This including spectroscopic
(MALDI-TOF, ESI, LC-MS Fluorescence), electrophoresis, immunochemical biochemical,
enzymatical analysis, TLC. QC (quality control) and QA (quality assurance) procedures
are also followed independently to offer you double guarantee for the highest quality
possible of every delivered conjugates. Moreover, our dedicated technical account
managers will guide your project through every step of the process and constantly
keep you informed of the latest project progress.
Visit our literature vaults for more references and citings.
For us to better understand your customized project, please complete our Bioconjugation Service Questionnaire. The more our chemists understand your project needs, the more accurate feedback we will be able to provide you. Providing us with your project details will enable us to recommend the best reagents to use for your own project. The most useful and readily available tools for bioconjugation projects are cross-linking reagents. A large number of cross-linkers, also known as bifunctional reagents, have been developed. There are several ways to classify the cross-linkers, such as the type of reactive group, hydrophobicity or hydrophilicity, and the length of the spacer between reactive groups. Other factors to consider are whether the two reactive groups are the same or different (for example, heterobifunctional or homobifunctional reagents), whether the spacer is cleavable, and whether the reagents are membrane permeable or impermeable. The most accessible and abundant reactive groups in proteins are the ϵ-amino groups of lysine. Therefore, a large number of the most common cross-linkers are amino selective reagents, such as imidoesters, sulfo-N-hydroxysuccinimide esters, and N-hydroxysuccinimide esters. Due to the high reactivity of the thiol group with N-ethylmaleimide, iodoacetate and a-halocarbonyl compounds, new cross-linkers have been developed that contain maleimide and a-carbonyl moieties. Usually, N-alkylmaleimides are more stable than their N-aryl counterparts.
In addition to the reactive groups on the cross-linkers, a wide variety of connectors and spacer arms have also been developed. The nature of the spacer arm, and also the length, play an important role in the functionality. Longer spacer arms are generally more effective when coupling large proteins or those with sterically protected reactive side-chains. Other important considerations are the hydrophobicity, hydrophilicity, and the conformational flexibility. Long aliphatic chains generally fold on themselves when in an aqueous environment, which makes the actual distance spanned by such linker arms less than expected. Instead, spacers that contain more rigid structures (for example, aromatic groups or cycloalkanes) should be used. These structures, however, tend to be very hydrophobic which could significantly decrease the solubility of the modified molecules or even modify some of their properties. In such cases, it is recommended to choose a spacer that contains an alkylether (PEO) chain. Bio-Synthesis offers several cross-linkers with PEO chains, such as thiol-binding homobifunctional reagents, heterobifunctional based, and their derivatives.
Once the project scope has collected, we will provide an appropriate quotation within 3-5 days. Orders can be placed with either a PO (Purchase Order) or credit card. We accept POs and major credit cards ( ). Your credit card will be billed under 'Bio-Synthesis, Inc.' Click here to download our credit reference form. For international orders, we must apply the full charge at the time of the order is placed. In the unlikely event that any given order cannot be filled, our guarantee will take the form of a full refund.